{"id":"99mtc-etarfolatide","phase":"phase_1","safety":{"commonSideEffects":[]},"status":"active","trials":["NCT03011320"],"aliases":["EC20","etarfolatide"],"patents":[],"pricing":[],"timeline":[],"aiSummary":"99mTc-Etarfolatide is a small molecule modality used in medical imaging, specifically in conditions such as non-small cell lung cancer and ovarian cancer. It is a technetium-99m labeled folate receptor-targeting agent, which is used in various clinical trials in combination with other treatments like docetaxel.","brandName":"99mTc-Etarfolatide","companyId":"endocyte","mechanism":{"_ai_source":"groq-llama-8b","explanation":"99mTc-Etarfolatide is a radioligand that binds to folate receptor beta, allowing for imaging of folate receptor-positive tumors.","oneSentence":"binds to folate receptor beta","_ai_confidence":"high"},"commercial":null,"companyName":"Endocyte","competitors":[],"genericName":"99mTc-Etarfolatide","indications":{"approved":[{"name":"Ovarian cancer"},{"name":"Breast cancer"}]},"labelChanges":[],"trialDetails":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"rwe":[],"genericFilers":[],"relatedDrugs":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"modality":"Small molecule","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"EU","regulator":"EMA","status":"withdrawn","approval_date":"2014-03-21T00:00:00.000Z","mah":"Endocyte Europe, B.V.","brand_name_local":"Folcepri","application_number":"EMEA/H/C/002570"}],"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":false,"score":2}}